Cargando…
An Anatomical Site and Genetic-Based Prognostic Model for Patients With Nuclear Protein in Testis (NUT) Midline Carcinoma: Analysis of 124 Patients
BACKGROUND: NUT midline carcinoma, renamed NUT carcinoma (NC), is an aggressive squamous cancer defined by rearrangement of the NUTM1 gene. Although a subset of patients can be cured, for the majority of patients the prognosis is grim. We sought to classify patients into risk groups based on molecul...
Autores principales: | Chau, Nicole G, Ma, Clement, Danga, Kristina, Al-Sayegh, Hasan, Nardi, Valentina, Barrette, Ryan, Lathan, Christopher S, DuBois, Steven G, Haddad, Robert I, Shapiro, Geoffrey I, Sallan, Stephen E, Dhar, Arindam, Nelson, Jeanenne J, French, Christopher A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7165803/ https://www.ncbi.nlm.nih.gov/pubmed/32328562 http://dx.doi.org/10.1093/jncics/pkz094 |
Ejemplares similares
-
Usefulness of Nuclear Protein in Testis (NUT) Immunohistochemistry in the Cytodiagnosis of NUT Midline Carcinoma: A Brief Case Report
por: Park, Heae Surng, et al.
Publicado: (2014) -
Therapeutic targeting of p300/CBP HAT domain for the treatment of NUT midline carcinoma
por: Zhang, Xin, et al.
Publicado: (2020) -
Comparative drug screening in NUT midline carcinoma
por: Beesley, A H, et al.
Publicado: (2014) -
Nuclear protein in testis midline carcinoma in a Turkish boy: a case report
por: Bayrak, Büşra Yaprak, et al.
Publicado: (2020) -
NUT midline carcinoma of the head and neck: current perspectives
por: Napolitano, M, et al.
Publicado: (2019)